Diddling around in 2017 re CFDA and that ambiguos ann re cfda in late 2017 should have been a red flag to everyone about this stock. I was out on that news and glad I was. Put that into some appreciating stocks.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game